Loading...
Loading...
India's heparin imports from CHINA total $508.4B across 406 shipments from 15 foreign suppliers. YANTAI DONGCHENG BIOCHEMICALS CO.,LTD leads with $507.7B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BIOLOGICAL E. LIMITED. This corridor reflects India's pharmaceutical import demand for heparin — a diversified sourcing base with multiple active suppliers from CHINA.

YANTAI DONGCHENG BIOCHEMICALS CO.,LTD is the leading Heparin supplier from CHINA to India, with import value of $507.7B across 28 shipments. The top 5 suppliers — YANTAI DONGCHENG BIOCHEMICALS CO.,LTD, YINO PHARMA LTD, NINGBO RENJIAN PHARMACEUTICAL GROUP CO.,LTD., YINO PHARMA LIMITED, M/S. CHANGZHOU QIANHONG BIO-PHARMA — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | YANTAI DONGCHENG BIOCHEMICALS CO.,LTD | $507.7B | 28 | 99.9% |
| 2 | YINO PHARMA LTD | $501.2M | 71 | 0.1% |
| 3 | NINGBO RENJIAN PHARMACEUTICAL GROUP CO.,LTD. | $86.0M | 2 | 0.0% |
| 4 | YINO PHARMA LIMITED | $24.1M | 75 | 0.0% |
| 5 | M/S. CHANGZHOU QIANHONG BIO-PHARMA | $14.4M | 14 | 0.0% |
| 6 | M/S.YANTAI DONGCHENG BIOCHEMICALS C | $10.2M | 6 | 0.0% |
| 7 | CHANGZHOU QIANHONG BIO-PHARMA CO., LTD. | $6.3M | 8 | 0.0% |
| 8 | SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | $5.6M | 8 | 0.0% |
| 9 | YANTAI DONGCHENG BIOCHEMICALS CO LTD | $2.9M | 5 | 0.0% |
| 10 | HUBEI ENORAY BIOPHARMACEUTICAL CO., LTD. | $2.6M | 14 | 0.0% |
| 11 | NINGBO RENJIAN PHARMACEUTICAL GROUP CO., LTD. | $2.1M | 1 | 0.0% |
| 12 | KAIPA PHARMA LIMITED | $2.0M | 4 | 0.0% |
| 13 | YANTAI DONGCHENG BIOCHEMICALS CO.LIMITED | $1.7M | 1 | 0.0% |
| 14 | YANTAI DONGCHENG BIOCHEMICALS CO LIMITED | $1.6M | 7 | 0.0% |
| 15 | DONGYING TIANDONG PHARMACEUTICAL CO.,LTD, | $1.5M | 6 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIOLOGICAL E. LIMITED | $507.7B | 41 | 99.9% |
| 2 | VIRCHOW BIOTECH PRIVATE LIMITED | $500.1M | 16 | 0.1% |
| 3 | RADHASHOK PHARMACHEM PRIVATE LIMITED | $86.0M | 2 | 0.0% |
| 4 | GLAND PHARMA LIMITED | $24.6M | 20 | 0.0% |
| 5 | TROIKAA PHARMACEUTICALS LIMITED | $12.1M | 32 | 0.0% |
| 6 | GLAND PHARMA LTD | $6.3M | 8 | 0.0% |
| 7 | ZYDUS HEALTHCARE LIMITED | $4.6M | 17 | 0.0% |
| 8 | EUGIA STERILES PRIVATE LIMITED | $4.5M | 1 | 0.0% |
| 9 | FCN IMPEX INDIA LLP | $4.2M | 22 | 0.0% |
| 10 | SAKAR HEALTHCARE LIMITED | $3.8M | 55 | 0.0% |
| 11 | PUJA'S PHARMACARE LLP | $3.7M | 10 | 0.0% |
| 12 | ACULIFE HEALTHCARE PRIVATE LIMITED | $3.0M | 18 | 0.0% |
| 13 | SYMBIO GENERRICS INDIA PRIVATE LIMITED | $2.7M | 23 | 0.0% |
| 14 | BIOLOGICAL E LIMITED | $2.7M | 11 | 0.0% |
| 15 | BIOLOGICAL E LTD | $2.4M | 3 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Heparin suppliers from CHINA to India include YANTAI DONGCHENG BIOCHEMICALS CO.,LTD, YINO PHARMA LTD, NINGBO RENJIAN PHARMACEUTICAL GROUP CO.,LTD.. The leading supplier is YANTAI DONGCHENG BIOCHEMICALS CO.,LTD with import value of $507.7B USD across 28 shipments. India imported Heparin worth $508.4B USD from CHINA in total across 406 shipments.
India imported Heparin worth $508.4B USD from CHINA across 406 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Heparin sourced from CHINA include BIOLOGICAL E. LIMITED, VIRCHOW BIOTECH PRIVATE LIMITED, RADHASHOK PHARMACHEM PRIVATE LIMITED. The largest buyer is BIOLOGICAL E. LIMITED with $507.7B in imports across 41 shipments.
The total value of Heparin imports from CHINA to India is $508.4B USD, across 406 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
406 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists